JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 12.36% |
| 3 | Healthcare | 9.31% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBC
2926
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $3.08M | ﹤0.01% |
286,823
+281,718
| +5,518% | +$2.94M |
|
2927
CALL
Kimco Realty
KIM
$16.4B
| $3.08M | ﹤0.01% |
167,100
+117,700
| +238% | +$2.13M |
|
2928
PUT
Advanced Micro Devices
AMD
$822B
| $3.07M | ﹤0.01% |
100,000
| – | – |
|
2929
Forte Biosciences
FBRX
$1.57B
| $3.07M | ﹤0.01% |
1,271
+62
| +5% | +$184K |
|
|
NVO
2930
CALL
Novo Nordisk
NVO
$201B
| $3.07M | ﹤0.01% |
+120,800
| New | +$2.99M |
|
2931
Assembly Biosciences
ASMB
$626M
| $3.06M | ﹤0.01% |
18,422
+1,470
| +9% | +$279K |
|
2932
Peoples Bancorp
PEBO
$1.49B
| $3.06M | ﹤0.01% |
95,208
+20,485
| +27% | +$654K |
|
2933
BWX Technologies
BWXT
$15.8B
| $3.06M | ﹤0.01% |
59,484
-10,495
| -15% | -$524K |
|
2934
AnaptysBio
ANAB
$1.7B
| $3.06M | ﹤0.01% |
56,072
+1,488
| +3% | +$107K |
|
2935
Equinor
EQNR
$97.2B
| $3.05M | ﹤0.01% |
154,383
+35,597
| +30% | +$751K |
|
2936
CALL
Capital One
COF
$139B
| $3.05M | ﹤0.01% |
34,100
-19,200
| -36% | -$1.72M |
|
2937
PUT
Bunge Global
BG
$21.7B
| $3.04M | ﹤0.01% |
55,200
-92,600
| -63% | -$4.94M |
|
2938
CALL
FirstEnergy
FE
$27.3B
| $3.04M | ﹤0.01% |
+71,500
| New | +$3M |
|
2939
iShares US Telecommunications ETF
IYZ
$1.23B
| $3.04M | ﹤0.01% |
103,081
+2,676
| +3% | +$79.6K |
|
2940
TORM
TRMD
$3.06B
| $3.03M | ﹤0.01% |
319,079
-927
| -0.3% | -$8.21K |
|
|
ARI
2941
Apollo Commercial Real Estate
ARI
$881M
| $3.03M | ﹤0.01% |
165,973
+62,343
| +60% | +$1.16M |
|
2942
CALL
Prologis
PLD
$134B
| $3.02M | ﹤0.01% |
38,000
-6,300
| -14% | -$480K |
|
|
2943
PUT
Prologis
PLD
$134B
| $3.02M | ﹤0.01% |
38,000
-73,200
| -66% | -$5.57M |
|
2944
Sixth Street Specialty
TSLX
$1.78B
| $3M | ﹤0.01% |
154,170
+12,757
| +9% | +$255K |
|
2945
Ambarella
AMBA
$3.58B
| $3M | ﹤0.01% |
67,775
-35,731
| -35% | -$1.6M |
|
2946
JPMorgan Diversified Return International Equity ETF
JPIN
$375M
| $3M | ﹤0.01% |
55,313
-42
| -0.1% | -$2.3K |
|
|
BRSL
2947
Brightstar Lottery PLC
BRSL
$2.16B
| $3M | ﹤0.01% |
237,017
-161,587
| -41% | -$2.2M |
|
|
AMRN
2948
PUT
Amarin Corp
AMRN
$296M
| $3M | ﹤0.01% |
8,000
-7,000
| -47% | -$2.56M |
|
2949
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.23B
| $2.99M | ﹤0.01% |
37,251
-827
| -2% | -$64.8K |
|
2950
CALL
PBF Energy
PBF
$8.58B
| $2.99M | ﹤0.01% |
100,000
| – | – |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.